All articles
News

Oral GLP-1s Are Here: What the Foundayo FDA Approval Means for the Peptide Community

For years, GLP-1 therapy meant a weekly injection. The FDA just changed that. Foundayo is the first oral GLP-1 approved for weight management, and the implications for the peptide community go far beyond convenience.

April 21, 20269 min read
Oral GLP-1s Are Here: What the Foundayo FDA Approval Means for the Peptide Community

For years, GLP-1 therapy meant a weekly injection. The FDA just changed that. Foundayo is the first oral GLP-1 approved for weight management, and the implications for the peptide community go far beyond convenience.

Peptide South Africa Research Research TeamEditorial

#GLP-1 agonist#2026#peptide news#weight loss#Foundayo#retatrutide#semaglutide#FDA approval#oral GLP-1#biohackingShare this articleTwitterLinkedInTrack Your Peptide Protocols

Use Peptide South Africa Research to log injections, calculate doses, access our peptide library, and optimize your protocols.

Download Peptide South Africa ResearchExplore More Peptide ResourcesFree peptide calculators·Peptide research hub·Peptide glossary·Semaglutide guide·BPC-157 guide·Best peptide calculator

Research disclaimer: Peptides discussed are for research and educational purposes only. They are not approved for human consumption unless specifically noted as FDA-approved medications. Always consult a qualified healthcare professional.